Clinical Trials · NCT01729819
Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 106
- Start date
- Jan 2013
- Locations
- 24 sites, United States
- Primary endpoint
- Change in Mean Number of Nocturnal Voids From Baseline